Tag Archives: IOVA

In a report released yesterday, Mark Breidenbach from Oppenheimer maintained a Buy rating on Iovance Biotherapeutics Inc (NASDAQ: IOVA), with a price target of $22. The company’s shares closed yesterday at $13.85. Breidenbach said: “Wednesday, we sat down with Iovance

In a report released today, Mark Breidenbach from Oppenheimer maintained a Buy rating on Iovance Biotherapeutics Inc (NASDAQ: IOVA), with a price target of $22. The company’s shares closed yesterday at $14.85. Breidenbach noted: “Thursday, on its 1Q18 earnings call,

Oppenheimer analyst Mark Breidenbach reiterated a Buy rating on Iovance Biotherapeutics Inc (NASDAQ: IOVA) today and set a price target of $22. The company’s shares closed yesterday at $19.15, close to its 52-week high of $19.60. Breidenbach said: “On Monday,

B.Riley FBR analyst Madhu Kumar reiterated a Hold rating on Iovance Biotherapeutics Inc (NASDAQ: IOVA) today and set a price target of $22. The company’s shares closed yesterday at $19.15, close to its 52-week high of $19.60. Kumar observed: “Yesterday,